Use access key #2 to skip to page content.
$54.52 -2.03 (-3.59%)
10/10/2008 4:00 PM

Celgene Corp (CELG)

CAPS Rating:
****

A biopharmaceutical company primarily engaged in the discovery, development and commercialization of innovative therapies designed to treat cancer and immune-inflammatory related diseases.

View All Commentary (CELG)

Recs

0

Avatar MarvyMarge (< 20) Submitted: 2/02/08 12:56 PM : Outperform Start Price: $59.80 CELG Score: 27.60

I believe Celgene will continue to be one of the top drug makers in the space because of their superior drugs now on the market. Their use of Thalimide in cancer patients has been very successul . Now they have a relatively new drug which has been approved, Revlimid, a miracle drug for cancer patients with multiple myeloma.

Report this Post Replies: 0 | Reply

Featured Broker Partners